Washington University School of Medicine in St. Louis has received a $10.8 million, five-year grant from the National Cancer Institute to continue its Specialized Program of Research Excellence (SPORE) in leukemia, one of only two such programs nationwide. This grant supports cutting-edge translational research that moves lab discoveries to clinical care and is part of […]
The Bone Marrow and Stem Cell Transplant Program at the Siteman Cancer Center, located at Barnes-Jewish Hospital and Washington University School of Medicine, has reached a significant clinical achievement, completing its 10,000th transplant on September 4. This milestone underscores the program’s standing as one of the nation’s oldest and largest transplant centers, reflecting decades of […]
The 27th Annual BMT & Cellular Therapy Patient Celebration took place on March 9, 2024 at the Hyatt Regency St. Louis. The annual celebration honors the strength and courage of stem cell transplant and cellular therapy patients and their families. It unites recent transplant patients with those who have been in recovery for years, fostering […]
The Top Doctors® selection process is purely based on merit, with no option for doctors to pay for inclusion. These top-tier healthcare providers exemplify excellence in both clinical care and interpersonal skills. For more details, visit the Top Doctors® website. Additionally, this list is published annually each August by St. Louis Magazine. Ramzi Abboud, MD […]
Todd Fehniger, MD, PhD, Professor of Medicine in the Division of Oncology, has been appointed to the Lymphoma Research Foundation’s Scientific Advisory Board. This board comprises experts who guide the foundation’s research agenda and funding priorities. Dr. Fehniger’s extensive experience in lymphoma research will contribute to the foundation’s mission to advance understanding and treatment of […]
Dr. Amanda Cashen, Associate Chief of Hematologic Malignancies and Ramaswamy Govindan, Associate Chief of Oncology, discuss some features of the new Siteman Ambulatory Cancer Center Building. Currently under construction and due to open in the fall of 2024, the new 9-story cancer center is over 657,000 square feet with 4 floors of clinic space to […]
The CheckPoints, a cover band of immunotherapy all-stars, has become a mainstay at the American Society of Clinical Oncology (ASCO) Annual Meeting. Comprised of luminaries in the field of cancer immunotherapy, The CheckPoints perform modern and classic rock hits. Led by Dr. Thomas Gajewski, the band features renowned scientists like Dr. Patrick Hwu, Nobel Prize […]
Brian Van Tine, MD, PhD, Professor of Medicine in the Division of Oncology is the senior author of a clinical trial of CAR-T (chimeric antigen receptor T-cells) cells director against MAGE-A4. 36 of patients with aggressive sarcomas had a tumor response including some patients who entered complete remissions.
The John F. DiPersio Immunotherapy Symposium will take place on Wednesday March 27, 2024. The symposium honors John DiPersio’s contributions to the understanding of the pathogenesis of and development of new treatments for hematopoietic malignancies. The symposium will feature presentations by three leaders in the field of cancer immunotherapy. Dr. Stanley Riddell (Fred Hutchinson […]
David DeNardo, Ph.D., is a Professor of Medicine in the Division of Oncology and Co-Director of the Tumor Immunology Program. His work on responses to cancer immunotherapy was recently highlighted on the NCI website. His research team is working to understand why responses to cancer immunotherapy vary among patients. In studying and uncovering mechanisms of […]